AlphaFold predicted structure
PHKG2 · P15735

Mean pLDDT
83.3/ 100
Confident
406 residues
Confidence breakdown
- Very high(≥ 90)60%
- Confident(70–90)20%
- Low(50–70)10%
- Very low(< 50)10%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
phosphorylase kinase catalytic subunit gamma 2
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Glycogen storage disease
BIALLELIC, autosomal or pseudoautosomalKetotic hypoglycaemia
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
Intellectual disability
glycogen storage disease IXc
glycogen storage disease due to liver phosphorylase kinase deficiency
disorder of glycogen metabolism
Glycogen storage disease due to glycogenin deficiency
Glycogen storage disease due to phosphorylase kinase deficiency
hereditary disease
Parkinson disease
neurodegenerative disease
Alzheimer disease
lysosomal storage disease
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Phosphorylase b kinase gamma catalytic chain, liver/testis isoform
Catalytic subunit of the phosphorylase b kinase (PHK), which mediates the neural and hormonal regulation of glycogen breakdown (glycogenolysis) by phosphorylating and thereby activating glycogen phosphorylase. May regulate glycogeneolysis in the testis. In vitro, phosphorylates PYGM (PubMed:35549678)
PHKG2 · P15735

Mean pLDDT
83.3/ 100
Confident
406 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0